Rabies virus, inactivated (purified chick embryo cell) · Rabies (before exposure)
Health Canada DIN 02267667. Check the product and formulation on your record before using a schedule.
Plan doses for this product →Three doses over 3 to 4 weeks.
RABAVERT is listed under Health Canada DIN 02267667. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.
02267667Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
A listed product may not be stocked or publicly funded.
These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.
For product-specific effects and precautions, check this DIN in the Health Canada product record and monograph. The general appointment steps above apply to all vaccinations.
No directly matching Pharmasist product guide was identified for this DIN. Use the linked Health Canada record to check your exact product.
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.
Three doses over 3 to 4 weeks for people at high risk of rabies exposure.
Pre-exposure series for very-high-risk and high-risk groups (laboratory workers, veterinarians, animal control, travellers to high-risk areas with limited access to care): days 0, 7 and 21 to 28. Moderate-risk people may use a two-dose day 0 and day 7 to 28 schedule. This is not the schedule after an animal bite.
Three doses on days 0, 7 and 21 to 28, with a blood test 2 to 4 weeks after the series.
Immunocompromised people in any risk group receive the full three-dose pre-exposure series on days 0, 7 and 21 to 28. A blood test 2 to 4 weeks after the series is mandatory; extra doses may be needed if the antibody level is inadequate.
Family guidance on pregnancy: After an exposure, treatment is always given. Pre-exposure vaccination is deferred unless the risk during pregnancy is increased.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.
Explore care options